TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients ...
Introduction Schizophrenia is a chronic disease that imposes serious physical, social, and economic burden on those affected by it.1 The disease affects more than 20 million individuals globally,2 and has a lifetime prevalence of ~1% globally3,4 and ~0.5–1 …